Bioxera Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.69 Cr
as on 16-11-2024
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 38.23 Cr
as on 16-11-2024
- Satisfied Charges ₹ 7.03 Cr
as on 16-11-2024
- Revenue -1.15%
(FY 2023)
- Profit -21.73%
(FY 2023)
- Ebitda -20.93%
(FY 2023)
- Net Worth 32.39%
(FY 2023)
- Total Assets 5.30%
(FY 2023)
About Bioxera Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.69 Cr.
The company currently has active open charges totaling ₹38.23 Cr. The company has closed loans amounting to ₹7.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Satish Gunjikar, Ajit Gunjikar, Sudha Gunjikar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH2005PTC156737
- Company No.
156737
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Bioxera Pharma Private Limited offer?
Bioxera Pharma Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Diabetes Medicine, Sexual Wellness Products, Fertility Enhancer, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Common Disease Medicines, Pharmaceutical Tablets, Chemical Compound, Ketones.
Who are the key members and board of directors at Bioxera Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Gunjikar  | Managing Director | 14-Oct-2005 | Current |
| Ajit Gunjikar | Managing Director | 14-Oct-2005 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudha Gunjikar | Whole-Time Director | 16-Oct-2005 | Current |
| Nitin Mangaonkar | Director | 16-Oct-2005 | Current |
Financial Performance of Bioxera Pharma.
Bioxera Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.15% decrease. The company also saw a substantial fall in profitability, with a 21.73% decrease in profit. The company's net worth Soared by an impressive increase of 32.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioxera Pharma?
In 2023, Bioxera Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ar-Ex Laboratories Private LimitedActive 68 years 9 monthsSatish Gunjikar, Ajit Gunjikar and 2 more are mutual person
Ar-Ex Specialities Private LimitedActive 1 year 11 monthsSatish Gunjikar and Ajit Gunjikar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Jul 2019 | ₹5.50 Cr | Open |
Others Creation Date: 26 Feb 2018 | ₹1.00 Cr | Open |
Others Creation Date: 12 Oct 2017 | ₹7.50 M | Open |
How Many Employees Work at Bioxera Pharma?
Bioxera Pharma has a workforce of 71 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioxera Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioxera Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
